Investing Profile

Anthony Philippakis

VCInvestor

Venture Partner at GV

gv.com/team/anthony-philippak...Cambridge, Massachusetts
Photo of Anthony Philippakis, Venture Partner at GV

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Yale University Network
91 CONNECTIONS
GV Network
22 CONNECTIONS
cb
GV Venture Partner
$250K - $50.0M
$25.0M
7
$100M
CompanyStageDateRound SizeTotal Raised
Genome Medical
Series CAug 2021$60M
$97M
Co-investors: David Shapiro (Alumni Ventures Group), Eli Casdin (Casdin Capital), Stephen Bloch (Canaan Partners), Francis Ho (Walden Catalyst Ventures), Amy Belt Raimundo (Kaiser Permanente Ventures)
Tenaya Therapeutics
Series CMar 2021$110M
Series BOct 2019$92M
$200M
Co-investors: Eli Casdin (Casdin Capital), Roderick Wong (RTW Investments)
Decibel Therapeutics
Series DNov 2020$82M
Series CJun 2018$55M
Series BJul 2017
$190M
Co-investors: Jens Eckstein (Apollo Health Ventures)
Gritstone Oncology
Series BSep 2017$93M
$200M
Co-investors: Peter Svennilson (The Column Group), Tom Woiwode (Versant Ventures)
scientist Broad InstitutePresent
Chief Data Officer Broad Institute2015 - Present
Venture Partner GV2012 - Present
Fellow, Cardiovascular Medicine Brigham and Women's Hospital2011 - 2015
Resident, Internal Medicine Brigham and Women's Hospital2009 - 2011
Harvard Medical School MD-PhD Biophysics
Cambridge University Part III Mathematics, Merit Class
Yale University BS Mathematics, Summa Cum Laude, Phi Beta Kappa, Distinction in Major
brophy/xavier